Skip to content

Late start for ART in pregnancy increases HIV transmission risk during breastfeeding period

Global evidence of lower adherence to ARVs after giving birth

ART for life cost effective for prevention of mother-to-child transmission in Uganda

Long-acting integrase inhibitor S/GSK1265744 active against multiple HIV subtypes

Dolutegravir combo beats Atripla for effectiveness and tolerability

Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

Long-acting fusion inhibitor albuvirtide looks promising in early studies

High rate of infections in people with HIV receiving Bio-Alcamid treatment for facial lipoatrophy

HIV and antiretroviral therapy increase risk of cardiovascular disease, shows meta-analysis